Table of Contents
Presented April 7, 2023.
Each month biotechnology, pharmaceutical and academic partners, large and small, working on treatments and a cure for myotonic dystrophy will sit down with our community to share their progress and answer your questions. Click here to learn more about Dyne Therapeutics.
Dr. Ashish Dugar, Chief Medical Affairs Officer at Dyne Therapeutics, presents on the ACHIEVE study and Dyne’s investigational medicine, DYNE-101. Q&A hosted by Molly White, Global Head of Patient Advocacy.
Click here to find all our upcoming Meet the DM Drug Developers dates!
